Canaccord Genuity set a $2.00 price objective on Liberty Health Sciences (CNSX:LHS) in a research note released on Tuesday. The firm currently has a speculative buy rating on the stock.

Shares of CNSX LHS opened at $1.39 on Tuesday. Liberty Health Sciences has a 12-month low of $0.63 and a 12-month high of $2.30.

In related news, insider Aphria Inc. sold 16,029,615 shares of the company’s stock in a transaction dated Thursday, July 26th. The shares were sold at an average price of $0.72, for a total transaction of $11,541,322.80.

Recommended Story: What is the yield curve?

Receive News & Ratings for Liberty Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Health Sciences and related companies with's FREE daily email newsletter.